Dave Sendecki

Dave Sendecki is a Senior Scientist specializing in Plasmids and Nucleic Acids at the Center for Breakthrough Medicines since January 2023. Prior to this role, Sendecki accumulated over a decade of experience at PhaseBio Pharmaceuticals, Inc., where positions included Senior Scientist in Process Development and roles in Fermentation and Upstream Processing. Earlier in Sendecki's career, contributions were made at GlaxoSmithKline as an Associate Scientist in Microbial and Cell Culture Development. Educational qualifications include a Bachelor’s degree in Biology from Millersville University of Pennsylvania, earned between 2002 and 2006.